DE68913397D1 - Verwendung von 5-heteroaryl- oder 5-arylsubstituierten Imidazo(2,1-a)isochinolinen. - Google Patents

Verwendung von 5-heteroaryl- oder 5-arylsubstituierten Imidazo(2,1-a)isochinolinen.

Info

Publication number
DE68913397D1
DE68913397D1 DE89810565T DE68913397T DE68913397D1 DE 68913397 D1 DE68913397 D1 DE 68913397D1 DE 89810565 T DE89810565 T DE 89810565T DE 68913397 T DE68913397 T DE 68913397T DE 68913397 D1 DE68913397 D1 DE 68913397D1
Authority
DE
Germany
Prior art keywords
isoquinolines
heteroaryl
aryl
substituted imidazo
imidazo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE89810565T
Other languages
English (en)
Other versions
DE68913397T2 (de
Inventor
William Joseph Houlihan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Sandoz Patent GmbH
Original Assignee
Sandoz AG
Sandoz Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG, Sandoz Patent GmbH filed Critical Sandoz AG
Application granted granted Critical
Publication of DE68913397D1 publication Critical patent/DE68913397D1/de
Publication of DE68913397T2 publication Critical patent/DE68913397T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
DE68913397T 1988-07-29 1989-07-25 Verwendung von 5-heteroaryl- oder 5-arylsubstituierten Imidazo(2,1-a)isochinolinen. Expired - Fee Related DE68913397T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22630588A 1988-07-29 1988-07-29
US07/302,720 US4910206A (en) 1986-07-14 1989-01-27 5-hetero-or aryl-substituted-imidazo(2,1-a)isoquinolines and their use as PAF receptor antagonists

Publications (2)

Publication Number Publication Date
DE68913397D1 true DE68913397D1 (de) 1994-04-07
DE68913397T2 DE68913397T2 (de) 1994-08-11

Family

ID=26920416

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68913397T Expired - Fee Related DE68913397T2 (de) 1988-07-29 1989-07-25 Verwendung von 5-heteroaryl- oder 5-arylsubstituierten Imidazo(2,1-a)isochinolinen.

Country Status (16)

Country Link
US (1) US4910206A (de)
EP (1) EP0357550B1 (de)
JP (1) JPH0273016A (de)
KR (1) KR910002445A (de)
AU (1) AU632487B2 (de)
CA (1) CA1336503C (de)
DE (1) DE68913397T2 (de)
DK (1) DK372089A (de)
ES (1) ES2062092T3 (de)
FI (1) FI893616A (de)
HU (1) HU206040B (de)
IE (1) IE63243B1 (de)
IL (1) IL91128A (de)
NO (1) NO177485C (de)
NZ (1) NZ230098A (de)
PT (1) PT91302B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989010143A1 (en) * 1988-04-27 1989-11-02 Schering Corporation Certain paf antagonist antihistamine combinations and methods
US5639782A (en) * 1992-03-04 1997-06-17 Center For Innovative Technology Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors
US5530141A (en) * 1992-03-04 1996-06-25 Center For Innovative Technology 2,4-diaryl-1,3-dithiolanes; 2,4-diaryl-1,3-dioxolanes; 2,4-diaryl-1,3-oxathiolanes; and 2,5-diaryl-1,3-oxathiolanes for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5648486A (en) * 1992-07-13 1997-07-15 Cytomed, Inc. Compounds and methods for the treatment of inflammatory and immune disorders
US5358938A (en) * 1992-07-13 1994-10-25 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5463083A (en) * 1992-07-13 1995-10-31 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5434151A (en) * 1992-08-24 1995-07-18 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
PT650485E (pt) 1992-07-13 2001-03-30 Millennium Pharm Inc 2,5-diaril-tetra-hidro-tiofenos -furanos e analogos para o tratamento de desordens inflamatorias e imunitarias
US5792776A (en) * 1994-06-27 1998-08-11 Cytomed, Inc., Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5703093A (en) * 1995-05-31 1997-12-30 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5750565A (en) * 1995-05-25 1998-05-12 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
FR2756560A1 (fr) * 1996-12-04 1998-06-05 Adir Nouveaux derives de l'imidazoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN1076728C (zh) * 1999-02-05 2001-12-26 浙江大学 2－芳基咪唑并[2,1－a]异喹啉的衍生物及其用途
CN112574176B (zh) * 2019-09-27 2024-03-15 隆泰申医药科技(南京)有限公司 一种杂芳基类化合物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4101553A (en) * 1974-01-02 1978-07-18 Sandoz, Inc. Imidazo[2,1-a]isoquinolines
HU172649B (hu) * 1975-04-24 1978-11-28 Gyogyszerkutato Intezet Sposob poluchenija novykh biologicheski aktivnykh lizergamidov
JPH01500270A (ja) * 1986-07-14 1989-02-02 サンド・アクチエンゲゼルシヤフト ５‐ヘテロ‐またはアリール‐置換された‐イミダゾ［２，１‐ａ］イソキノリン類

Also Published As

Publication number Publication date
HU206040B (en) 1992-08-28
IL91128A0 (en) 1990-03-19
DK372089D0 (da) 1989-07-27
CA1336503C (en) 1995-08-01
FI893616A0 (fi) 1989-07-28
AU632487B2 (en) 1993-01-07
HUT50630A (en) 1990-03-28
KR910002445A (ko) 1991-02-25
US4910206A (en) 1990-03-20
ES2062092T3 (es) 1994-12-16
NO177485C (no) 1995-09-27
NO893062D0 (no) 1989-07-27
AU3901789A (en) 1990-02-01
DE68913397T2 (de) 1994-08-11
IL91128A (en) 1996-01-31
PT91302A (pt) 1990-02-08
NO893062L (no) 1990-01-30
FI893616A (fi) 1990-01-30
JPH0273016A (ja) 1990-03-13
EP0357550A3 (de) 1991-04-03
EP0357550A2 (de) 1990-03-07
IE892459L (en) 1990-01-29
NZ230098A (en) 1992-02-25
IE63243B1 (en) 1995-04-05
DK372089A (da) 1990-01-30
PT91302B (pt) 1995-03-01
NO177485B (no) 1995-06-19
EP0357550B1 (de) 1994-03-02

Similar Documents

Publication Publication Date Title
DE69020796T2 (de) Direkt-Elektroplattieren von Durchgangslöchern.
DE3684704D1 (de) Perfluorierung von aethern.
DK336587D0 (da) Alfa-aryl-alfa-phenylethyl-1h-1,2,4-triazol-1-propannitriler
DE3764410D1 (de) Vielfachanordnung von lasern.
DE68904679D1 (de) Elektroplattierung von kleinen partikeln.
KR900700567A (ko) 2,3-디플루오로비페닐
DE69204290D1 (de) Verwendung von 1,2,2,3,3-pentafluorpropan.
DE3781751T2 (de) Ueberzugsmittel.
DE68913397T2 (de) Verwendung von 5-heteroaryl- oder 5-arylsubstituierten Imidazo(2,1-a)isochinolinen.
FI88303B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 2,3-disubstituerade isoxazolidiner
ATE112172T1 (de) Targetformer von antitumor-methyltrithioagenzien.
ATE125794T1 (de) Prodrogen von antiinflammatorischen 3-acyl-2- oxindol-1-carboxamiden.
FI881812A0 (fi) Foerfarande foer regenerering av betningssyror i zinkgalvaniseringsprocesser.
DE69002136D1 (de) Saccharidderivate von protocatechualdehyd.
FI881521A (fi) Kontinuerlig oevervakningsanordning och -foerfarande foer faststaellande av graden av fullstaendighet av massakok.
DE3779211D1 (de) Verwendung von dihydrobenzopyranderivaten.
DE3681026D1 (de) Oxidierungsverfahren von 2,6-diisopropylnaphthalin.
DK291687D0 (da) 2-phenylacetyl-1,3,5-cyklohexantrioner
ATE102035T1 (de) Verwendung von 5-heteroaryl- oder 5arylsubstituierten imidazo(2,1-a)isochinolinen.
DE3881393T2 (de) Dehydrobromierung von substituiertem alpha-halocumol.
FI880759A0 (fi) Anordning foer neddoppning av foeremaol i vaetska.
DE3688548T2 (de) Sulfomaleinisierung von polyolefinen.
FI924177A (fi) Foerfarande foer framstaellning av 1,5-bensotiazepinderivat
FI883463A0 (fi) Anordning foer undervattensarbete.
DE3760738D1 (de) 1,1-dialkoxy-2-methyl-4,4-diacyloxybutenes

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee